WORKPLACE DRUG TESTING IN CALIFORNIA

Deterring Workday Cannabis Use
Under California A.B. 2188

Maintain a legally compliant cannabis testing program
using a recent use breath test

A new law in California – Assembly Bill 2188 – limits many California employers from taking adverse employment action based on a test result that reflects off-duty cannabis use. As of January 1, 2024, CA A.B. 2188 eliminates urine and hair testing as options for most employers since they detect “non-psychoactive THC metabolites” that indicate past use. This law DOES NOT prevent employers from testing for cannabis. Employers may continue to conduct cannabis testing and take action based on positive test results using drug tests that do not screen for non-psychoactive THC metabolites and do not reflect past use that occurs outside of the workday.

Recent use cannabis breath testing is the ideal solution for many California employers. This test fully complies with the new law by:

Green Check
Only testing for the psychoactive THC molecule (not metabolites)
Green Check
Providing the shortest detection window of all drug test types, limiting detection to the workday
Green Check
Supporting ongoing testing programs in alignment with OSHA guidance

A NEW CANNABIS TEST FOR CA A.B. 2188

Drug testing is a proven deterrent to workday substance use. Navigating changing cannabis testing laws, however, can feel overwhelming. While some employers may consider dropping cannabis testing in response to CA A.B. 2188, removing THC testing increases an organization’s exposure to safety risks and costs associated with workday cannabis use.

HL_WebsiteIcons_200x200px_MJLeaf

Among companies who drug test, THC accounts for more than 50% of all drug test positives

HL_WebsiteIcons_200x200px_Unions

Marijuana users are 1.5X more likely to work for companies who don’t drug test

HL_Icons_Cross_Red

53% of employers who dropped cannabis testing experienced an increase in safety incidents

Governing bodies such as OSHA and ACOEM assert that employers have a legal and ethical responsibility to protect employees from workplace illness, harm, or injury. A.B. 2188 does not remove an employer’s obligation to maintain a drug and alcohol-free workplace as specified in the California Health and Safety Code.

“Employers have a legal responsibility to protect employees from workplace illness or injury under the OSHA general duty clause. Employers also have an ethical responsibility to prevent impaired workers from exposing themselves, their co-workers, and/or the general public to risk and harm.”

– American College of Occupational and Environmental Medicine

marijuana stay in your system mobile

RISKS OF DISCONTINUING CANNABIS TESTING

Hire more cannabis users

Increased employee turnover + absenteeism

Reduced productivity

Exposure to additional risks + incidents

Greater costs related to safety issues

Reduced workers’ comp discounts

BREATH TESTING FULLY ALIGNS WITH CA A.B. 2188

The intent of CA A.B. 2188 is to help prevent employer discrimination against off-duty employee cannabis use. Since both recreational and medical marijuana are legal in California, lawmakers introduced the law to prevent companies from punishing employees who test positive based on off-duty cannabis use away from work. They zeroed in on two indicators relevant to cannabis testing:

Target of Detection

Prevents impacted employers from using urine and hair tests that detect non-psychoactive THC metabolites as a basis for adverse employment actions.

Window of Detection

Prevents some employers from taking adverse employment actions based on a cannabis drug test result that reflects off-duty use away from the workplace.

WATCH OUR WEBINAR ON CA A.B. 2188

Sammie Dabbs and Tae Phillips discuss the complexities of California A.B. 2188 for employers, its restrictions on adverse actions based on positive marijuana test results, and how recent use breath testing technology is a potential solution for employers facing these challenges.

BREATH TESTING ADVANTAGES UNDER CA A.B. 2188

A recent use breath test detects the active THC molecule and provides the industry’s shortest detection window of 2-3 hours, fully aligning with workday use language in a way that not even oral fluid testing and its 12-72 hour detection window can support.

Start Leveraging the Benefits of Breath